Nurses' Resource Center
Learn About: Seizure Preparedness Planning: Interviews with Healthcare ProfessionalsDoctors and nurses talk about Seizure Preparedness Planning and DIASTAT AcuDial.
Order Patient Education Materials, Videos, & Carrying Cases Reprints to Read and Share:- Back-to-School Guide for Teaches and Parents
- Epilepsy and the Adolescent Female
- Recognizing Seizures in School
- Schools are Legally Obligated to Administer Emergency Seizure Medication
- Telling Others Who Need to Know
Now patients can have DIASTAT AcuDial delivered directly to their home. Learn about our partnership with Axium Specialty Pharmacy
Valeant-Sponsored ProgramsValeant Pharmaceuticals is committed to helping patients with epilepsy/seizure disorders live life more fully, with greater peace of mind and confidence. Learn about programs and partnerships.
Websites For More Information IMPORTANT SAFETY INFORMATION
DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.
In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.
DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.
In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.
© Valeant Pharmaceuticals North America 2007
Legal and Privacy Statement
DIASTAT® AcuDial™ is a registered trademark of Valeant Pharmaceuticals North America. D896-0607 Site Map